Big Pharma’s Statehouse Siege: How the Drug Industry Spent Record Sums to Kill Generic Medicine Bills in 2023
While Congress debated federal drug pricing, pharmaceutical companies quietly deployed a record lobbying offensive at the state level — targeting generic drug legislation and PBM reform in at least 24…